With an ann on current operations at mindarie followed by WIM150 pfs, a re-rating is not far off imo.A great specy - or should i say "producer"
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress